Approval · Notice of Compliance 1053 · 2000
NASONEX: Notice of Compliance 1053
Issued August 4, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1053
- Date
- August 4, 2000
- Company
- Schering Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: adjunctive treatment to antibiotics for acute episodes of sinusitis in adults and children 12 years of age and older
- Therapeutic class
- Corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NASONEX | Not yet assigned | — |
Medicinal ingredients
- MOMETASONE FUROATE 50 MCG per ACT